XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash $ 1,295,059
Prepaid expenses 125,886 15,000
Total current assets 1,420,945 15,000
Deferred offering costs 12,500
Investments held in trust account 56,200,264
Total Assets 57,621,209 27,500
Current liabilities    
Accounts payable and accrued expenses 152,972 3,000
Total current liabilities 152,972 5,500
Commitments and Contingencies (Note 6)
Shareholders’ Equity:    
Preference shares, no par value; 1,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024
Addition paid-in capital 1,876,524 25,000
Retained earnings (accumulated deficit) 646,853 (3,000)
Total shareholders’ equity 2,523,377 22,000
Total Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ Equity 57,621,209 27,500
Related Party    
Current liabilities    
Due to a related party 2,500
Class A Ordinary Shares    
Current liabilities    
Class A ordinary shares, no par value; 100,000,000 shares authorized; 5,500,000 shares subject to possible redemption as of December 31, 2025 and none issued and outstanding as of December 31, 2024 54,944,860
Shareholders’ Equity:    
Ordinary shares, value
Class B Ordinary Shares    
Shareholders’ Equity:    
Ordinary shares, value [1]
[1] Class B ordinary shares have been retroactively restated to reflect the Sponsor’s forfeiture of 206,250 Founder Shares on July 30, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option (see Note 5).